Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005;28(5):715-22.
doi: 10.1007/s10545-005-0003-3.

High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease

Affiliations

High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease

A C Hauser et al. J Inherit Metab Dis. 2005.

Abstract

Anderson-Fabry disease is a rare lysosomal storage disorder. It results from a deficiency of the lysosomal alpha-galactosidase A and leads to progressive accumulation of globotriaosylceramide in the endothelium and tissue cells of various organs. Some of the typical clinical findings such as tiredness, dry skin, myalgia and arthralgia as well as vague gastrointestinal complaints are also symptoms of hypothyroidism. Therefore, we studied the thyroid function in patients with Anderson-Fabry disease. Thyroid function was studied in 11 patients (6 female, 5 male) with Anderson-Fabry disease by measuring thyroid-stimulating hormone (TSH) and free thyroxine serum levels. Nine patients had chronic kidney disease with stage 1 and two with stage 5. Subclinical hypothyroidism (normal serum free thyroxine concentrations along with elevated serum TSH levels) was found in 4 of 11 patients (36.4%). Subclinical hypothyroidism was observed in both male and female patients as well as in patients with stage 1 and stage 5 kidney disease. Subclinical hypothyroidism is a common finding in patients with Anderson-Fabry disease, showing an excess prevalence as compared to the normal population. The high frequency seems to be relevant regarding the potential consequences of a hypothyroid state.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Wien Klin Wochenschr. 2003 Apr 30;115(7-8):235-40 - PubMed
    1. N Engl J Med. 1978 Oct 19;299(16):847-52 - PubMed
    1. Clin Endocrinol (Oxf). 1988 Jul;29(1):63-75 - PubMed
    1. J Am Soc Nephrol. 2002 Jun;13 Suppl 2:S139-43 - PubMed
    1. J Clin Endocrinol Metab. 2001 Oct;86(10):4860-6 - PubMed

MeSH terms